Track LogicBio Therapeutics, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

LogicBio Therapeutics, Inc. LOGC · Stock Open LogicBio Therapeutics, Inc. in new tab

13.80 USD
EPS
-1.09
P/B
2.16
ROE
-6.87
Beta
2.08
Loading chart...
Key Metrics
Earnings dateMarch 11, 2027
EPS-1.09
Book Value6.38
Price to Book2.16
Debt/Equity29.46
% Insiders2.751%
Growth
Revenue Growth-0.01%
Earnings Growth1.99%
Estimates
Forward P/E-345.00
Forward EPS-0.04

DCF valuation

Model fair value for LogicBio Therapeutics, Inc. (LOGC)
Result
Sign in to run the valuation for LOGC.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

LogicBio Therapeutics, Inc. Logo LogicBio Therapeutics, Inc. Analysis (LOGC)

United States Health Care Official Website Stock

Is LogicBio Therapeutics, Inc. a good investment? LogicBio Therapeutics, Inc. (LOGC) is currently trading at 13.80 USD.

Earnings Schedule: LogicBio Therapeutics, Inc. is expected to release its next earnings report on March 11, 2027. The market consensus estimate for Forward EPS is -0.04.

Investor FAQ

Does LogicBio Therapeutics, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is LogicBio Therapeutics, Inc.?

LogicBio Therapeutics, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be March 11, 2027. The company currently has a trailing EPS of -1.09.

Company Profile

ContextLogic Holdings Inc. focuses on seeking to develop and grow a de novo business and finance potential future bolt-on acquisitions of assets or businesses. The company was incorporated in 2010 and is headquartered in Oakland, California.

Exchange Ticker
NMS (United States) LOGC
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
April 12, 2023 1:30
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion